Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Daniel

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Emergency Medicine|October 27, 2004
Updated treatment algorithmGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
The Journal of Emergency Medicine|October 27, 2004
Intramuscular antipsychotics: clinical experience reviewGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
The Journal of Emergency Medicine|October 27, 2004
Standard therapies for acute agitationGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
CNS Spectrums|February 23, 2022
The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophreniaRoger S McIntyre, David G Daniel, Eduard Vieta, et al.
Journal of Psychiatric Research|April 9, 2013
A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive DisorderSteven D Targum, Pamela C Wedel, Jill Robinson, et al.
Innovations in Clinical Neuroscience|June 18, 2020
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?David G Daniel, Alan Kott, Jay Saoud, et al.
Journal of Psychiatric Practice|May 25, 2007
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulationsDavid G Daniel, Glenn W Currier, Dan L Zimbroff, et al.
CNS Spectrums|December 31, 2005
From clinical research to clinical practice: a 4-year review of ziprasidoneCharles B Nemeroff, Jeffrey A Lieberman, Peter J Weiden, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2008
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophreniaDaniel E Casey, David G Daniel, Carol Tamminga, et al.
Innovations in Clinical Neuroscience|February 21, 2012
Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scaleMichael H Allen, David G Daniel, Dennis A Revicki, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Emergency Medicine|October 27, 2004
Updated treatment algorithmGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
The Journal of Emergency Medicine|October 27, 2004
Intramuscular antipsychotics: clinical experience reviewGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
The Journal of Emergency Medicine|October 27, 2004
Standard therapies for acute agitationGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
CNS Spectrums|February 23, 2022
The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophreniaRoger S McIntyre, David G Daniel, Eduard Vieta, et al.
Journal of Psychiatric Research|April 9, 2013
A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive DisorderSteven D Targum, Pamela C Wedel, Jill Robinson, et al.
Innovations in Clinical Neuroscience|June 18, 2020
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?David G Daniel, Alan Kott, Jay Saoud, et al.
Journal of Psychiatric Practice|May 25, 2007
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulationsDavid G Daniel, Glenn W Currier, Dan L Zimbroff, et al.
CNS Spectrums|December 31, 2005
From clinical research to clinical practice: a 4-year review of ziprasidoneCharles B Nemeroff, Jeffrey A Lieberman, Peter J Weiden, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2008
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophreniaDaniel E Casey, David G Daniel, Carol Tamminga, et al.
Innovations in Clinical Neuroscience|February 21, 2012
Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scaleMichael H Allen, David G Daniel, Dennis A Revicki, et al.
Pageof 4